Pathos
Where the Future of Drug Development Begins
- Headquarters
- Chicago, Illinois
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- pathos.ai
- Total Funding
- $365.0M
- Last Round
- $365.0M Series DMay 2025
About
Pathos is an AI-enabled clinical-stage biotech re-engineering drug development for precision oncology. Using the largest multimodal oncology dataset and thousands of AI agents, we simulate trials, identify responsive patient subgroups, and accelerate therapies from hypothesis to clinic. Our platform de-risks development, improves success rates, and delivers better outcomes faster.
Tech Stack
Backend
Python
AI/ML
C++CUDA
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free Account